🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday

Published 09/01/2024, 15:59
Updated 09/01/2024, 17:10
© Reuters.  Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
JNPR
-
ILMN
-
URBN
-
SRPT
-
OFIX
-
AYI
-
CENX
-
HPE
-
ACMR
-
ESTA
-
ACCD
-
SHC
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Shares of Acuity Brands, Inc. (NYSE: AYI) rose sharply Tuesday’s session after the company reported better-than-expected first-quarter earnings.

Acuity Brands reported a first-quarter FY24 net sales decline of 9% year-over-year to $934.7 million, marginally missing the consensus of $935.1 million. Adjusted EPS of $3.72 beat the consensus of $3.23.

Acuity Brands shares jumped 10.2% to $225.51 on Tuesday.

Here are some other big stocks recording gains in today’s session.

  • Juniper Networks, Inc. (NYSE: JNPR) shares gained 21.5% to $36.71. Hewlett Packard Enterprise Co (NYSE: HPE) is reportedly in advanced discussions to acquire networking equipment competitor Juniper Networks.
  • Accolade, Inc. (NASDAQ: ACCD) jumped 17.2% to $13.61 following third-quarter results.
  • Century Aluminum Company (NASDAQ: CENX) shares rose 14.4% to $12.18. B. Riley Securities upgraded Century Aluminum from Neutral to Buy and raised the price target from $10 to $14.
  • ACM Research, Inc. (NASDAQ: ACMR) surged 12.8% to $19.22. ACM Research said it sees FY23 revenue of $530 million to $545 million.
  • Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) gained 10.9% to $13.98.
  • Nukkleus Inc. (NASDAQ: NUKK) gained 9.6% to $2.27.
  • Wheels Up Experience Inc. (NYSE: UP) jumped 9.6% to $4.66.
  • Urban Outfitters, Inc. (NASDAQ: URBN) climbed 9.1% to $39.17 after the company reported a 10% increase in total company net sales for the two months ended Dec. 31, 2023.
  • Sotera Health Company (NASDAQ: SHC) rose 9.1% to $17.22. Sotera Health presented FY23 revenue guidance of $1.04 billion to $1.05 billion at 42nd Annual J.P. Morgan Healthcare Conference.
  • NextNav Inc. (NASDAQ: NN) gained 9% to $5.04.
  • MaxCyte, Inc. (NASDAQ: MXCT) rose 8.9% to $5.00 after the company announced strong preliminary fourth-quarter and full year 2023 revenue results.
  • IGM Biosciences, Inc. (NASDAQ: IGMS) gained 8.5% to $12.04.
  • Orthofix Medical Inc. (NASDAQ: OFIX) gained 8.4% to $14.40. Orthofix Medical reported preliminary FY23 net sales of $746.3 million versus consensus of $741.52 million.
  • Establishment Labs Holdings Inc. (NASDAQ: ESTA) rose 8.4% to $29.95. Establishment Labs announced a $50 Million private placement and preliminary unaudited financial results for the fourth quarter and fiscal year 2023.
  • Illumina, Inc. (NASDAQ: ILMN) gained 8.2% to $144.72 after the company reported preliminary FY23 consolidated revenue guidance above estimates.
  • Sarepta Therapeutics, Inc. (NASDAQ: SRPT) gained 6.6% to $109.40. Wedbush analyst Andreas Argyrides reiterated Sarepta Therapeutics with an Outperform and maintained a $224 price target.

Now Read This: Dow Tumbles Over 200 Points; US Trade Gap Narrows In November

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.